Interestingly, MFAP4 is highly expressed only in gliomas and diametrically opposite in other cancers, which may be due to the fact that gliomas are highly heterogeneous tumors whose development involves a variety of molecular mechanisms. Here, MFAP4 is linked to central nervous system cancer.